{{Rsnum
|rsid=10736303
|Gene=FGFR2
|Chromosome=10
|position=123334457
|Orientation=plus
|GMAF=0.3774
|Gene_s=FGFR2
|Assembly=GRCh37.p5
|GenomeBuild=37.3
|dbSNPBuild=135
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}
{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 27.4 | 39.8 | 32.7
| HCB | 17.5 | 51.8 | 30.7
| JPT | 24.1 | 47.3 | 28.6
| YRI | 0.7 | 11.6 | 87.8
| ASW | 0.0 | 22.8 | 77.2
| CHB | 17.5 | 51.8 | 30.7
| CHD | 21.1 | 48.6 | 30.3
| GIH | 23.8 | 49.5 | 26.7
| LWK | 0.9 | 13.6 | 85.5
| MEX | 21.8 | 49.1 | 29.1
| MKK | 0.6 | 18.6 | 80.8
| TSI | 15.7 | 49.0 | 35.3
| HapMapRevision=28
}}{{PMID Auto
|PMID=22452962
|Title=A genome-wide association study identifies a breast cancer risk variant in ERBB4 at 2q34: results from the Seoul Breast Cancer Study
|OA=1
}}

{{PMID Auto
|PMID=18285324
|Title=Common variation in the fibroblast growth factor receptor 2 gene is not associated with endometriosis risk.
|OA=1
}}

{{PMID Auto
|PMID=19223389
|Title=FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation.
|OA=1
}}

{{PMID Auto
|PMID=19497954
|Title=Histone-acetylated control of fibroblast growth factor receptor 2 intron 2 polymorphisms and isoform splicing in breast cancer.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}